Skip to Content

NVR J 125 (Exjade 125 mg)

Generic Name: deferasirox

Pill with imprint NVR J 125 is White, Round and has been identified as Exjade 125 mg. It is supplied by Novartis Corporation.

Exjade is used in the treatment of iron overload; thalassemia; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Exjade 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR J 125

Exjade 125 mg NVR J 125

Exjade

Generic Name
deferasirox
Imprint
NVR J 125
Strength
125 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Chelating agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Corporation
National Drug Code (NDC)
00078-0468

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.